Compare MEDP & AMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | AMCR |
|---|---|---|
| Founded | 1992 | 1926 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 19.0B |
| IPO Year | 2016 | N/A |
| Metric | MEDP | AMCR |
|---|---|---|
| Price | $547.73 | $8.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $465.18 | $10.40 |
| AVG Volume (30 Days) | 277.0K | ★ 22.7M |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | ★ 25.36 | N/A |
| EPS | ★ 14.32 | 0.32 |
| Revenue | $2,358,373,000.00 | ★ $17,401,000,000.00 |
| Revenue This Year | $21.48 | $57.16 |
| Revenue Next Year | $11.90 | $1.28 |
| P/E Ratio | $38.28 | ★ $25.88 |
| Revenue Growth | 13.88 | ★ 28.42 |
| 52 Week Low | $250.05 | $7.67 |
| 52 Week High | $626.26 | $10.47 |
| Indicator | MEDP | AMCR |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 46.46 |
| Support Level | $530.96 | $8.31 |
| Resistance Level | $626.26 | $8.59 |
| Average True Range (ATR) | 18.24 | 0.14 |
| MACD | -8.14 | -0.03 |
| Stochastic Oscillator | 17.60 | 11.39 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Amcor is a global producer of plastic packaging primarily for the fast-moving consumer goods industry. About 90% of earnings are exposed to the flexible packaging business. This is soft disposable plastic for a variety of food, drink, healthcare, and hygiene products. The remainder of earnings are from the Latin and North American rigids business, which is primarily beverage bottling for the soft drink industry. Operating in more than 35 countries, Amcor has market share in its established regions of North America, Latin America, Europe, and Asia-Pacific. About half of group sales are derived from North America and the remainder is split equally between Western Europe and emerging markets. Australia and New Zealand sales make up less than 5% of group sales.